NEWS
Med-Tech News | Immunexpress’ rapid sepsis test receives FDA clearance

The test is an aid in differentiating sepsis from infection-negative systemic inflammation in hospitalised patients suspected of sepsis. Immunexpress has been a leader in host response sepsis diagnostics, and this second FDA clearance translates its biomarker technology to the sample-to-answer Biocartis Idylla near-patient testing platform. SeptiCyte RAPID contains all the reagents needed for quantification of […]

Rheumatology Network | James Woody, MD, PhD: Repurposing Adalimumab for Treating Dupuytren’s Disease

Rheumatology Network interviewed James Woody, MD, PhD, to understand the key findings of the Phase 2b clinical trial, “Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD).” During the study, investigators repurposed adalimumab to treat this disabling condition that causes fingers to curl irreversibly into the palm. Woody is the CEO of 180 Life Sciences. James Woody, MD, PhD: [Dupuytren’s […]

Cannabis Business Times | Unrivaled Brands Looks to Build Off Its First Harvest’s Success

If you walk into The Kremlin, you can be hit by the warm, welcoming smell of cannabis—just make sure you’re in the Bay Area around harvest time, not Moscow. The Kremlin is Unrivaled Brands’ cultivation facility in Oakland, Calif., where the vertically integrated multi-state operator recently harvested its first crop. The company launched The Kremlin in September. […]